Clinical Trials Logo

Clinical Trial Summary

The investigators have previously demonstrated the utility of transdermal testosterone in in vitro fertilization (IVF) low responder patients. Now, the investigators want to evaluate the efficacy of luteinizing hormone (LH) activity added to recombinant follicular stimulating hormone (FSHr) during ovarian stimulation in these patients.


Clinical Trial Description

Studies in macaques have indicated that androgens have some synergistic effects with follicular stimulating hormone (FSH) on folliculogenesis. Our previous clinical studies demonstrated the usefulness of pretreatment with transdermal testosterone in low-responder IVF patients.

There is controversy on the usefulness of recombinant luteinizing hormone (LHr) added to FSHr in ovarian stimulation of low responder patients. Thus, our present study has been designed to compare ovarian stimulation with FSHr alone versus LHr added to FSHr when transdermal testosterone pretreatment is used. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Other Complications Associated With Artificial Fertilization

NCT number NCT01291212
Study type Interventional
Source Hospital Clinic of Barcelona
Contact
Status Active, not recruiting
Phase N/A
Start date January 2011
Completion date September 2011

See also
  Status Clinical Trial Phase
Completed NCT01774006 - Comparison of Individual Culture and Group Culture of Preimplantation Embryos in Human IVF Treatments N/A
Completed NCT01461395 - Polscope Sperm: A Non-invasive Method to Assess DNA Damage in Individual Sperm N/A
Completed NCT02333253 - Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase Phase 3